We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
PepGen
PEPG
$131M
| $196K | ﹤0.01% |
+12,251
| New | +$176K |
|
|
VRNA
2277
DELISTED
Verona Pharma
VRNA
| $195K | ﹤0.01% |
+13,500
| New | +$197K |
|
2278
Acacia Research
ACTG
$448M
| $195K | ﹤0.01% |
38,939
-4,577
| -11% | -$23.7K |
|
|
NIU
2279
Niu Technologies
NIU
$208M
| $192K | ﹤0.01% |
110,222
-94,209
| -46% | -$193K |
|
|
GIFI
2280
DELISTED
Gulf Island Fabrication
GIFI
| $191K | ﹤0.01% |
+31,415
| New | +$211K |
|
|
UROY
2281
Uranium Royalty Corp
UROY
$400M
| $189K | ﹤0.01% |
83,961
-170,816
| -67% | -$424K |
|
|
MAGN
2282
Magnera Corp
MAGN
$489M
| $187K | ﹤0.01% |
10,343
+2,667
| +35% | +$57.4K |
|
2283
Contango Silver & Gold Inc
CTGO
$551M
| $185K | ﹤0.01% |
+10,245
| New | +$209K |
|
2284
Kearny Financial
KRNY
$594M
| $183K | ﹤0.01% |
+29,740
| New | +$170K |
|
2285
CSP Inc
CSPI
$81M
| $182K | ﹤0.01% |
12,236
-24,364
| -67% | -$362K |
|
|
BRKL
2286
DELISTED
Brookline Bancorp
BRKL
| $182K | ﹤0.01% |
+21,798
| New | +$191K |
|
2287
Rayonier Advanced Materials
RYAM
$573M
| $178K | ﹤0.01% |
+32,807
| New | +$160K |
|
|
TERN
2288
DELISTED
Terns Pharmaceuticals
TERN
| $177K | ﹤0.01% |
25,985
-160,024
| -86% | -$969K |
|
2289
PUT
Mastercard
MA
$487B
| $176K | ﹤0.01% |
400
-4,800
| -92% | -$2.19M |
|
2290
B&G Foods
BGS
$291M
| $176K | ﹤0.01% |
21,721
-85,048
| -80% | -$839K |
|
2291
uniQure
QURE
$2.63B
| $175K | ﹤0.01% |
+39,078
| New | +$190K |
|
2292
Biomea Fusion
BMEA
$91.1M
| $174K | ﹤0.01% |
38,672
-3,900
| -9% | -$39.6K |
|
2293
Laureate Education
LAUR
$5.25B
| $172K | ﹤0.01% |
11,500
+1,000
| +10% | +$15K |
|
2294
MasterBrand
MBC
$1.12B
| $172K | ﹤0.01% |
+11,700
| New | +$194K |
|
2295
CBAK Energy Technology Ltd
CBAT
$45.4M
| $171K | ﹤0.01% |
+124,698
| New | +$157K |
|
2296
Cooper-Standard Automotive
CPS
$508M
| $170K | ﹤0.01% |
13,703
-15,027
| -52% | -$215K |
|
2297
Hanmi Financial
HAFC
$942M
| $168K | ﹤0.01% |
+10,049
| New | +$157K |
|
2298
Outdoor Holding Co
POWW
$250M
| $168K | ﹤0.01% |
100,000
-84,100
| -46% | -$202K |
|
|
TWKS
2299
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $167K | ﹤0.01% |
+58,948
| New | +$158K |
|
|
PL.WS
2300
CALL
DELISTED
Planet Labs PBC Warrants
PL.WS
| $167K | ﹤0.01% |
90,000
-30,000
| -25% | -$4.17K |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.